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Abstract
Background: Iron is involved in important vital functions as an essential component of the oxygen-transporting
heme mechanism. In this study we aimed to evaluate whether oxidative metabolites from maternal cigarette
smoke could affect iron homeostasis in the brain of victims of sudden unexplained fetal and infant death, maybe
through the induction of maternal hemoglobin damage, such as in case of methemoglobinemia.
Methods: Histochemical investigations by Prussian blue reaction were made on brain nonheme ferric iron
deposits, gaining detailed data on their localization in the brainstem and cerebellum of victims of sudden death
and controls. The Gless and Marsland’s modification of Bielschowsky’s was used to identify neuronal cell bodies
and neurofilaments.
Results: Our approach highlighted accumulations of blue granulations, indicative of iron positive reactions, in the
brainstem and cerebellum of 33% of victims of sudden death and in none of the control group. The modified
Bielschowsky’s method confirmed that the cells with iron accumulations were neuronal cells.
Conclusions: We propose that the free iron deposition in the brain of sudden fetal and infant death victims could
be a catabolic product of maternal methemoglobinemia, a biomarker of oxidative stress likely due to nicotine
absorption.
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Background
In mammals, iron is a vital constituent of the oxygen-
carrrier hemoglobin (Hb). Human Hb is a tetramer con-
sisting of a pair of a-like globin chains and a pair of b-
like chains. Each chain is bound to a prosthetic heme
group, consisting of an iron atom in the ferrous state
located at the center of a porphyrin ring; this structure
has a high affinity for oxygen. Thus, Hb is best known
for its oxygen-carrying capacity, which facilitates the
transport of oxygen from the lungs to the tissues [1-3].
There are numerous causes of hemoglobin-related dis-
eases. A distinction can be made between genetically
inherited diseases, such as thalassemias and sickle cell
disease [4-6], and acquired disorders, such as methemo-
globinemia [7-9], a rare condition characterized by the
presence of a greater concentration than the normal phy-
siological range of 1-2% methemoglobin in erythrocytes.
Despite their different causes, these Hb disorders all
arise from an oxidative denaturation of Hb. Oxidative
injury can give rise to hemolysis with the consequent
release into the circulation of Hb denatured products
and of ferric iron (Fe3+), that is the oxidised form of the
normal reduced ferrous (Fe2+) state. This free iron is
characterized by its inability to bind and transport oxy-
gen [10-12]. During pregnancy, it can cross the placen-
tal-fetal barrier and inhibit the release of oxygen into
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fetal tissues, inducing hypoxia. Ferric iron also readily
permeates through the fetal blood-brain barrier, causing,
besides brain hypoxia, direct long-term DNA damage to
neuronal cells regarded as selectively vulnerable [13].
We previously reported a high susceptibility of the
autonomic nervous system (ANS) to oxidative stress
caused by maternal cigarette smoking in pregnancy,
with consequent alterations of nuclei and/or structures
controlling the vital activities, in victims of sudden fetal
and infant death [14-17]. In this study, we aimed to
evaluate whether oxidative metabolites of nicotine could
also affect iron homeostasis in the brain of these vic-
tims, maybe through the induction of maternal Hb
damage. The study was conducted by investigating, by
means of Perls’ Prussian Blue reaction, the possible pre-
sence of free iron in the ferric form in brain tissues of
victims of unexplained death, aged from 25 gestational
weeks to 10 postnatal months, and evaluating a possible
relation with maternal smoking in pregnancy.
Methods
In total, 56 brains were collected from 24 fresh still-
births (25-40 gestational weeks, with a peak from 36 to
40 weeks) and 32 infants aged 1-10 months (mean age:
3 months).
This was a selected set of cases, all sent to our
Research Center in application of the 2006 guidelines
stipulated by Italian law n.31 “Regulations for Diagnos-
tic Post Mortem Investigation in Victims of sudden
infant death syndrome (SIDS) and sudden intrauterine
unexpected death (SIUD)“. This law decrees that all
infants with suspected SIDS who died suddenly in Ita-
lian regions within the first year of age, as well as all
fetuses who died after the 25th week of gestation with-
out any apparent cause, must undergo an in-depth ana-
tomo-pathological examination, particularly of the
autonomic nervous system [18,19].
Ethics-Ethics approval for this study was granted by
the Italian Health’s Ministry in accordance with the
above-mentioned Italian Law n. 31. Parents of all sub-
jects (SIDS, SIUD) and controls provided written
informed consent to both autopsy and genetic study,
under protocols approved by the Milan University
L. Rossi Research Center institutional review board.
After fixation in 10% phosphate-buffered formalin, the
brainstem and cerebellum, the main structures analyzed
in our studies, were processed and embedded in
paraffin.
Transverse serial sections of the midbrain, pons,
medulla oblongata, and cerebellum samples were made
at intervals of 50-60 μm. For each level, serial 5 μm sec-
tions were obtained, two of which were routinely stained
for histological examination using hematoxylin-eosin
and Klüver-Barrera and one was submitted to Perls’
Prussian Blue reaction for histochemical demonstration
of the ferric iron content. In addition, in selected cases
(showing brain iron accumulation by Perls’ Prussian
Blue reaction), adjacent sections were submitted to a
modified Bielschowsky’s method (Gless and Marsland’s
modification). This is the method of choice in the wri-
ter’s experience for visualizing nervous cells, and thus
evaluating if the cells with iron granulations are really
neurons. The remaining sections were saved and stained
as deemed necessary for further investigations.
In the Perls’ Prussian Blue reaction [20] the ferric
iron, released from an attachment to protein by treat-
ment with diluted hydrochloric acid, reacts with a
diluted solution of potassium ferrocyanide to produce
an insoluble blue compound, namely ferric ferrocyanide
(Prussian Blue), according to the following reaction:
3K4[Fe2+(CN6)] + 4Fe3+Cl2  Fe4+[Fe2+(CN)6]3 + 12KCL
(K ferrocyanide) (ferric chloride) (Prussian Blue) (K chloride)
Practically, sections were firstly deparaffinized and
hydrated in distilled water, then immersed for 60 min-
utes in a mix of equal parts of hydrochloric acid 2% in
aqueous solution and potassium ferrocyanide 2% of aqu-
eous solution prepared immediately before use. The
slides were afterwards washed in distilled water and
counterstained with Kernechtrot solution (0.1 gr of
nuclear fast red + 5 g of aluminum sulfate dissolved in
100 ml of distilled water, followed by filtration and addi-
tion of thymol as preservative).
The Gless and Marsland’s modification of Bielschows-
ky’s method is a development of the silver impregnation
method that basically depends on silver oxide (or hydro-
xide) dissolved in ammoniacal solution. This method
selectively allows to a brown stain of neuronal cell
bodies and neurofilaments [21].
The routine histological evaluation of the brainstem
was focused on the locus coeruleus and the parabra-
chial/Kölliker-Fuse complex in the rostral pons/caudal
mesencephalon; on the retrotrapezoid nucleus, the
superior olivary complex and the facial/parafacial com-
plex in the caudal pons; on the hypoglossus, the dorsal
motor vagal, the tractus solitarius, the ambiguus, the
pre-Bötzinger, the inferior olivary, the raphé and the
arcuate nuclei in the medulla oblongata.
In the cerebellum, the cortex layers (external granular
layer, molecular layer, Purkinje cell layer and internal
granular layer) and the medullary deep nuclei (the den-
tate nucleus, the fastigial nucleus, the globose nucleus
and the emboliform nucleus) were examined.
In 36 cases, after the in-depth histopathological exam-
ination the death remained totally unexplained. A diag-
nosis of sudden intrauterine unexplained death (SIUD)
was established for 16 fetuses, who died suddenly after
the 25th gestational week before complete expulsion or
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retraction from the mother. Sudden infant death syn-
drome (SIDS) was diagnosed in 20 infants who died
within the first year of life. In the remaining 20 cases, 9
stillbirths, and 11 infant deaths, a precise cause of death
was formulated at autopsy. These cases were used as
controls. The related infant death diagnoses in this
group were: congenital heart disease (n = 5), severe
bronchopneumonia (n = 2), myocarditis (n = 1), pul-
monary dysplasia (n = 2), and mucopolysaccharidosis
type I (n = 1). Specific diagnoses among the fetal deaths
included: chorioamnionitis (n = 6) and congenital heart
disease (n = 3).
For every case, a complete clinical history was col-
lected. Additionally, mothers were asked to complete a
questionnaire on their smoking habit, detailing the num-
ber of cigarettes smoked before, during and after preg-
nancy. Fifteen of the 36 SIDS/SIUD mothers (42%) were
active smokers before and during the pregnancy, smok-
ing more than 3 cigarettes/day. The remaining 21
mothers (58%) admitted no history of cigarette smoking.
Four of the 20 mothers in the control group (20%)
reported a smoking habit, while the remaining 16
mothers (80%) were non smokers.
Statistical analysis
Spearman’s rho rank correlation test was used to test
the correlation between maternal smoking and altera-
tions of brain iron homeostasis in the groups of victims.
Statistical calculations were carried out on a personal
computer with SPSS statistical software (version 11.0;
SPSS Inc., Chicago, IL, USA). The selected threshold
level for statistical significance was p < 0.05.
Results
Application of the Blue Prussian method highlighted
accumulations of blue granulations, indicative of non-
heme Fe3+-positive reactions, in the brainstem and cere-
bellum of 12 (33%) of the 36 SIUD/SIDS victims and in
none of the control group. In the positive cases, iron
deposits were widespread in brain parenchyma or loca-
lized in specific areas showing a variable extent and
intensity. We observed large areas with a strong deposi-
tion of blue granules, particularly in the area postrema
(Figure 1), in the basal nuclei of the pons (Figure 2) and
in cerebellar parenchyma, both in the subcortical region,
below the internal granular layer, and in the area of the
dentate nucleus (Figure 3). A less marked positivity was
seen in the field of the trigeminal nucleus. The iron
deposits were scattered along the interstitium or, more
frequently, concentrated in the neuronal cytoplasma. In
these cases, the modified Bielschowsky’s method con-
firmed that the cells with iron accumulations were neu-
ronal cells (Figure 4). The observation of mitotic or
multinucleated iron-positive neurons was not
uncommon. Besides, we visualized an iron positive reac-
tion in endothelial cells of many capillaries in the blood-
brain barrier (Figure 5).
Table 1 shows the regional distribution of Fe3+ in the
brains of the 12 victims of sudden death showing an
iron positive reaction, as well as correlations of the iron
findings with both morphological alterations and a
maternal smoking habit.
A highly significant correlation was evident between
maternal smoking and alterations of brain iron homeos-
tasis. In fact, in 11 of the 12 victims the mother smoked
before and during pregnancy (p < 0.01).
In addition, routine histological examination of the
autonomic nervous system showed structural alterations
of various brainstem and cerebellum structures. Fre-
quently we observed hypoplasia/agenesis of the arcuate
nucleus, pre-Bötzinger nucleus, inferior olivary nucleus,
serotonergic raphé nuclei, parabrachial/Kölliker-Fuse
nucleus, parafacial nucleus in the medulla oblongata/
pons, and delayed cerebellar cortex maturation.
Discussion
Iron is indispensable for vital biological functions such
as oxygen transport, mitochondrial energy production,
DNA synthesis and DNA repair [22-24]. At least 75% of
the body’s iron is found within erythrocytes in the form
of “heme iron”. “Nonheme” iron is bound prevalently to
transferrin, an abundant circulating protein that binds
Figure 1 Area postrema- A) Ferric iron positivity in a SIUD victim
who died at 36 gestational weeks (case no.3). B) Free iron negativity
in an age-matched control case. Staining: Perls’ Prussian Blue
reaction for ferric iron-Magnification A) B): 10×.
Figure 2 Pontine basal nuclei- A) Ferric iron positivity in a SIUD
victim who died at 32 gestational weeks (case no.4). B) Free iron
negativity in an age-matched control case. Staining: Perls’ Prussian
Blue reaction for ferric iron-Magnification A) B): 20×.
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and delivers iron throughout the systemic circulation to
all tissues, except the central nervous system (CNS) that
is separated from the systemic circulation by the blood-
brain barrier (BBB) [25].
Crossing of the iron-transferrin complex to the brain
occurs by receptor-mediated endocytosis through
endothelial cells of BBB capillaries [26-28]. This com-
plex can then circulate in the brain interstitium, supply-
ing iron to neuronal cells and participating in important
neuronal functions, thanks to its ability to serve as both
an electron donor and acceptor. In particular, its contri-
bution to neurotransmitter synthesis, myelin formation
and other crucial vital processes such as DNA synthesis
makes iron essential for normal development and func-
tioning of the CNS [29,30].
Moreover, the same chemical properties that make
bound iron a highly versatile component in numerous
vital activities can cause toxicity if the iron is
unshielded. Iron toxicity is largely based on “Fenton
chemistry”, whereby excess free iron reacts with reactive
oxygen intermediates, including hydrogen peroxide
(H2O2) and the superoxide anion (O2
-)-both by-products
of aerobic metabolism-to produce an increase in reactive
oxygen species (ROS) such as the hydroxyl radical (OH·)
[31].
ROS are highly unstable due to the presence of
unpaired electrons that are responsible for initiating oxi-
dation. Even if, under normal conditions, free radical
species are important for biological functions such as
fighting infection or coordinating inflammation [32],
excessive free radicals production can induce tissue
damage by attacking lipids, DNA, and proteins [33,34].
In this study we investigated the presence of free iron
accumulations in brain histological sections in a wide
set of victims of sudden fetal death and SIDS, making
use of Perl’s Prussian Blue reaction. In this, one of the
oldest histochemical methods ferric iron, if present,
reacts with a dilute solution of potassium ferrocyanide
to produce an insoluble blue compound (Prussian blue).
We observed diffuse blue granulations, scattered and/
or assembled in different brainstem and cerebellum
areas, in a consistent subset of these victims (33%) but
in none of the control cases. Of particular interest was
the finding, in 4 SIUD and 4 SIDS victims, of a positive
iron reaction in endothelial cells of capillaries of the
blood-brain barrier. Capillaries in the CNS are unusual
in that they are sealed with tight junctions, without the
fenestrations that characterize capillaries of the systemic
circulation. So, drugs and nutrients cannot pass between
these cells. Furthermore, the oxidised free iron is
promptly seized by the transferrin receptors that densely
populate the endothelial cells of BBB capillaries [27,35],
to immobilize it and so to protect neuronal cells from
oxidative damage. In fact, brain cells have relatively low
antioxidant defenses [36] such as superoxide dismutase,
catalase, and glutathione, that usually work in conjunc-
tion to combat free radicals [37].
Despite this defensive mechanism, experimental stu-
dies have demonstrated that non-transferrin-bound iron
Figure 3 Cerebellum-Ferric iron positivity in: A) subcortical region
and B) parenchyma in the dentate nucleus area in a 6 month-old
victim of SIDS (case no.9). In C) and D) equivalent iron-negative
regions in an age-matched control case. Staining: Perls’ Prussian Blue
reaction for ferric iron-Magnification A)C): 10x; B)D): 20×.
Figure 4 Comparison between Perls’ Prussian Blue reaction (in
A) and modified Bielschowsky’s method (in B) in consecutive
brain histological sections of a 7 month-old SIDS case (no.8).
The cells with blue iron accumulations in A correspond to brown
neuronal cells in B-Magnification A)B): 20×.
Figure 5 Blood-brain barrier vessels- A) Iron positivity in
endothelial cells of a victim of SIUD aged 36 gestational weeks
(case no.3). B) Iron negativity in an age-matched control case.
Staining: Perls’ Prussian Blue reaction for ferric iron-Magnification A)
B): 20×.
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is able to readily cross the BBB, at a faster rate of trans-
fer than the complex formation [27,38]. The observa-
tion, in our 8 cases, that the positive reaction in BBB
capillary endothelial cells was constantly associated to
widespread iron deposits in different neuronal regions,
confirms these studies.
The finding in 4 SIDS victims of mitotic figures and
bi/multinucleated iron-positive neurons was noteworthy.
It is postulated that in prenatal CNS ontogeny, neuro-
blasts from the neuroepithelial matrix undergo mitotic
activity and migrate to reach their definitive location,
where they differentiate into mature neurons [39]. So,
after birth, the mitotic activity has ceased in fully differ-
entiated neurons.
We believe that the nuclear divisions we observed in
this study are a mitotic response to the presence of a
cytoplasmic iron excess, in agreement with different stu-
dies suggesting a role of intracellular iron in the induc-
tion of replication activities. In particular, Anderson et
al. demonstrated that iron can interfere with the p21
gene, which is involved in the activation of genes related
to DNA replication and mitosis [40]. In a study of
human prostatic and renal cancers, Nemoto et al. [41]
claimed that iron cooperates with zinc to activate telo-
merase, and by maintaining a sufficient chromosomal
telomere length to ensure DNA replication and an
unlimited number of irregular cell divisions.
The induction of both DNA synthesis and nuclear
division in mature nervous cells of SIDS victims could
imply the formation of daughter nuclei with an imbal-
anced DNA content, resulting in uncontrolled neuronal
transformation and in disruption of the CNS
homeostasis.
In addition, we propose a correlation between the
widespread presence of iron molecules and the struc-
tural alterations observed in different nuclei and/or
structures of the brainstem and cerebellum. In fact, free
iron may induce neuronal damage by directly acting on
DNA, proteins and other cellular components through
an excessive production of reactive free radicals [42]. In
support of this hyopothesis, different works have shown
that iron accumulation in the brain contributes to
Table 1 Regional distribution of Fe3+ in brain of SIUD/SIDS victims and correlation with the alterations of the central
nervous system and with the maternal smoking habit
Case
no.
Diagnosis Age at
death
BBB Iron positivity CNS structural alterations Maternal
smoking
Brainstem localization Cerebellum localization Yes
1 SIUD 39 gw + ++
+
inferior olivary
n
trigeminal n.
+ dentate n. arcuate n. hypoplasia
pre-Bötzinger n. hypoplasia
parafacial n. hypoplasia
No
2 SIUD 41 gw - + diffuse ++ subcortical parafacial n. hypoplasia Yes
3 SIUD 36 gw ++
+
-
+++
+
area postrema
tractus
solitarius n
- - parafacial n. hypoplasia Yes
4 SIUD 32 gw + ++ diffuse - - arcuate n. hypoplasia
raphè n. hypoplasia
Yes
5 SIUD 40 gw ++ + superior olivary
n
++
+++
Subcortical
dentate n.
parabrachial/Köllike-rFuse
hypoplasia
Yes
6 SIDS 4 m ++ ++ area postrema* ++ dentate n. cerebellar cortex immaturity Yes
7 SIDS 3 m - +++ basal pontine
n*
++ diffuse pre-Bötzinger n. hypoplasia Yes
8 SIDS 7 m ++ +++ basal pontine
n*
+++
+++
subcortical
dentate n.
arcuate n. hypoplasia
raphè n. hypoplasia
inferior olivary n. hypoplasia
Yes
9 SIDS 6 m ++ ++ diffuse* +++
+++
subcortical
dentate n.
raphè n. hypoplasia Yes
10 SIDS 2 m - ++ diffuse ++ diffuse raphè n. hypoplasia
cerebellar cortex immaturity
Yes
11 SIDS 3 m ++ ++ diffuse + diffuse arcuate n. hypoplasia
raphè n. hypoplasia
Yes
12 SIDS 1 m - +
++
trigeminal n.
diffuse
++
++
subcortical
dentate n.
hypoglossal n. hypoplasia
raphè n. hypoplasia
Yes
The intensities of iron deposition were: weak (+), strong (++), very strong (+++)
gw = gestational weeks; m = postnatal months
BBB = blood/brain barrier; n = nucleus
* = presence of mitotic and/or multinucleated neurons.
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neurodegenerative diseases, notably Alzheimer’s disease,
Parkinson’s disease and Huntington’s disease [43-45].
We also envisage the possibility that Prussian blue-
positive reactions indicate accumulations of “insoluble”
ferric iron molecules that are unavailable for cellular
use, resulting in a neuronal iron deficiency. Given the
importance of high iron uptake in brain development
[29,30], this imbalance could contribute to the patho-
genic mechanisms underlying sudden fetal death and
SIDS.
The mechanisms that lead to iron accumulation are
not completely understood.
Iron accumulations observed in the brain of fetuses
and infants could be ascribed to an immaturity of the
regulatory system of the iron homeostasis, that is parti-
cularly critical during periods of rapid growth and dif-
ferentiation such as the fetal and neonatal stages [46].
Another plausible explanation could be the diffusion of
oxidants into the circulation. Neonatal and fetal hemo-
globin in these conditions are more likely to release free
iron than adult hemoglobin [47].
We propose that the excess of free iron in the CNS
could arise from maternal Hb alterations, as in the case
of methemoglobinemia. Methemoglobin (MetHb) is
defined as a ferric derivative of Hb, that cannot reversi-
bly bind oxygen under physiological partial oxygen pres-
sure [7-9]. In normal conditions the level of MetHb is
lower than 1% of the total Hb but it may increase when
erythrocytes are affected by a variety of congenital, idio-
pathic, toxic and environmental factors.
Methemoglobinaemia, that represents a life-threaten-
ing complication of exposure to oxidants, is defined by
the presence of a greater concentration than the normal
physiological level of 1-2% MetHb in erythrocytes.
Hemolysis is a well-known consequence of methemoglo-
binemia. Many of the chemical agents that oxidize
hemoglobin to methemoglobin are also capable of indu-
cing erythrocyte injury responsible for hemolysis and
consequent release of free iron molecules with toxic
properties [48].
Besides, MetHb affects the function of the capillary
endothelium of the blood-brain barrier, increasing the
apoptotic degeneration and facilitating the passage and
the deposition of toxic Fe3+ in the fetal brain [49,50].
Mohorovic et al. [51-53] point out the role of MetHb
catabolism and reported that MetHb with prooxidant
property is an early biomarker of oxidative stress
which places the pregnancy at risk. As source of ferric
(Fe3+) form concentrated in various brain regions may
impair the health of newborns, children and adults.
Pregnant complications, such as anemia, threatened
abortion/premature labor and signs of preeclampsia
have been observed by Tabacova et al. [54] signifi-
cantly related to maternal MetHb. Hjell et al. point out
that methemoglobinemia can be found also in new-
borns [55]. These authors observed in a neonatal
intensive care unit high concentrations of MetHb
among neonates born at 25-30 weeks of gestation and/
or with a birth weight < 1000 g.
In most cases MetHb is the result of exposure to oxi-
dant drugs or chemicals, including cigarette smoke.
Cigarette smoke is a highly complex mixture of over
7000 chemical compounds distributed in the aqueous,
gas and tar phases of the smoke [55]. In the gas phase
the smoke comprises high concentrations of oxidants/
free radicals (> 1015 molecules per puff) [56,57].
In our study, 11 of the 12 victims of sudden death
with iron deposits had a smoker mother. This highly
significant correlation supports our view that iron accu-
mulations in the brains of fetuses and newborns could
be due to maternal methemoglobinemia, in all likelihood
an effect of oxidants in cigarette smoke.
Free radical species may also be due to air pollution.
Oxidative stress accompanied by increases of ROS pro-
duction is, in fact, one of the mechanisms through
which airborne pollutants, such as oxidant gases (ozone,
nitrogen dioxide, sulphur dioxide) or particulate matter
cause adverse effects on human Hb [58,59].
Unfortunately, even if MetHb can be rapidly quanti-
tated by spectrophotometry, in our study data on the
maternal Hb typing were not available.
Conclusions
Our research work will continue with the aim of con-
firming the involvement of the mother’s MetHb level
and of iron, as its catabolic product, in causing neuronal
damage in victims of sudden fetal death and SIDS.
If this should prove true it will be of fundamental clin-
ical importance to develop preventive treatment strate-
gies that can be applied before irreversible fetal brain
damage occurs. Therefore, it is extremely useful to eval-
uate the plasma MetHb concentration in pregnant
women and, in view of the evidence that maternal
smoking is one of the main contributors to Hb altera-
tions, to warn women that smoking places their fetus at
serious risk of brain abnormalities that could also lead
to sudden, apparently unexplained death.
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